Processa Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Processa Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q4 2023.
  • Processa Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $146K, a 35.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $146K -$81.5K -35.8% Dec 31, 2023 10-K 2024-03-29
Q3 2023 $167K -$79.9K -32.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $188K +$159K +549% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $208K +$156K +303% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $228K +$153K +207% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $247K +$151K +157% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $28.9K -$88.3K -75.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $51.6K -$86.5K -62.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $74.2K -$84.4K -53.2% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $95.9K -$63.3K -39.7% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $117K -$62.4K -34.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $138K -$61.4K -30.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $159K -$60.5K -27.6% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $159K -$79K -33.2% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $180K -$77.3K -30.1% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $200K -$75.7K -27.5% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $219K -$74.1K -25.3% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $238K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $257K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $275K Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $293K Jan 2, 2019 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.